Qingdao Haier Biomedical Co Ltd (688139) — Capital Reinvestment Ratio
Qingdao Haier Biomedical Co Ltd (688139) has a Capital Reinvestment Ratio of 7.36x as of June 2023, meaning it reinvests 7% of its operating cash flow (CN¥7.33 Million) in capital expenditures (CN¥53.93 Million). See 688139 equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Qingdao Haier Biomedical Co Ltd Capital Reinvestment Ratio (2016–2025)
This chart tracks Qingdao Haier Biomedical Co Ltd's Capital Reinvestment Ratio across 10 annual periods. Check how aggressively does Qingdao Haier Biomedical Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Qingdao Haier Biomedical Co Ltd (2016–2025)
Year-by-year Capital Reinvestment Ratio for Qingdao Haier Biomedical Co Ltd from 2016 to 2025. For live market cap and broader valuation context, see Qingdao Haier Biomedical Co Ltd (688139) total market value.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.45x | CN¥267.89 Million | CN¥119.25 Million | ▲ +2.5% |
| 2024 | 0.43x | CN¥291.67 Million | CN¥126.70 Million | ▼ -38.9% |
| 2023 | 0.71x | CN¥249.26 Million | CN¥177.18 Million | ▲ +52.8% |
| 2022 | 0.47x | CN¥632.43 Million | CN¥294.24 Million | ▲ +43.8% |
| 2021 | 0.32x | CN¥632.43 Million | CN¥204.69 Million | ▲ +153.4% |
| 2020 | 0.13x | CN¥696.62 Million | CN¥88.99 Million | ▼ -78.7% |
| 2019 | 0.60x | CN¥280.49 Million | CN¥168.40 Million | ▲ +29.0% |
| 2018 | 0.47x | CN¥149.00 Million | CN¥69.33 Million | ▲ +155.8% |
| 2017 | 0.18x | CN¥148.32 Million | CN¥26.98 Million | ▲ +176.8% |
| 2016 | 0.07x | CN¥220.72 Million | CN¥14.50 Million | — |